L&C BIO financial statements

엘앤씨바이오KRX:290650 · KOSDAQ · Healthcare · sector #23
₩57,800+10.31%
2026-10-07 close

L&C BIO's published financial data is dated 2026-10-04. 2024 revenue was KRW 72.09B. 2024 operating profit was KRW 2.53B.

Reported results

L&C BIO notifications

Quantus Signal · live data · not investment advice · Privacy Policy